Global Over The Counter (OTC) Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Over The Counter (OTC) Drugs market size was valued at USD 159420 million in 2023 and is forecast to a readjusted size of USD 216090 million by 2030 with a CAGR of 4.4% during review period.
Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Over The Counter (OTC) Drugs industry chain, the market status of Hospital Pharmacies (Analgesics, Dermatology Products), Retail Pharmacies (Analgesics, Dermatology Products), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Over The Counter (OTC) Drugs.
Regionally, the report analyzes the Over The Counter (OTC) Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Over The Counter (OTC) Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Over The Counter (OTC) Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Over The Counter (OTC) Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Analgesics, Dermatology Products).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Over The Counter (OTC) Drugs market.
Regional Analysis: The report involves examining the Over The Counter (OTC) Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Over The Counter (OTC) Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Over The Counter (OTC) Drugs:
Company Analysis: Report covers individual Over The Counter (OTC) Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Over The Counter (OTC) Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).
Technology Analysis: Report covers specific technologies relevant to Over The Counter (OTC) Drugs. It assesses the current state, advancements, and potential future developments in Over The Counter (OTC) Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Over The Counter (OTC) Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Over The Counter (OTC) Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Over The Counter (OTC) Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Over The Counter (OTC) Drugs, with revenue, gross margin and global market share of Over The Counter (OTC) Drugs from 2019 to 2024.
Chapter 3, the Over The Counter (OTC) Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Over The Counter (OTC) Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Over The Counter (OTC) Drugs.
Chapter 13, to describe Over The Counter (OTC) Drugs research findings and conclusion.
Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Over The Counter (OTC) Drugs industry chain, the market status of Hospital Pharmacies (Analgesics, Dermatology Products), Retail Pharmacies (Analgesics, Dermatology Products), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Over The Counter (OTC) Drugs.
Regionally, the report analyzes the Over The Counter (OTC) Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Over The Counter (OTC) Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Over The Counter (OTC) Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Over The Counter (OTC) Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Analgesics, Dermatology Products).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Over The Counter (OTC) Drugs market.
Regional Analysis: The report involves examining the Over The Counter (OTC) Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Over The Counter (OTC) Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Over The Counter (OTC) Drugs:
Company Analysis: Report covers individual Over The Counter (OTC) Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Over The Counter (OTC) Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).
Technology Analysis: Report covers specific technologies relevant to Over The Counter (OTC) Drugs. It assesses the current state, advancements, and potential future developments in Over The Counter (OTC) Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Over The Counter (OTC) Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Over The Counter (OTC) Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Analgesics
- Dermatology Products
- Gastrointestinal Products
- Vitamins, Mineral, and Supplements (VMS)
- Weight Loss/Dietary Products
- Ophthalmic Products
- Sleeping Aids
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacy
- Others
- Bayer AG
- Merck KGaA
- Novartis
- Johnson & Johnson
- GlaxoSmithKline
- Alkem Laboratories
- Teva Pharmaceutical Industries
- Pfizer
- Sun Pharma
- Allergan
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Over The Counter (OTC) Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Over The Counter (OTC) Drugs, with revenue, gross margin and global market share of Over The Counter (OTC) Drugs from 2019 to 2024.
Chapter 3, the Over The Counter (OTC) Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Over The Counter (OTC) Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Over The Counter (OTC) Drugs.
Chapter 13, to describe Over The Counter (OTC) Drugs research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Over The Counter (OTC) Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Over The Counter (OTC) Drugs by Type
1.3.1 Overview: Global Over The Counter (OTC) Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Over The Counter (OTC) Drugs Consumption Value Market Share by Type in 2023
1.3.3 Analgesics
1.3.4 Dermatology Products
1.3.5 Gastrointestinal Products
1.3.6 Vitamins, Mineral, and Supplements (VMS)
1.3.7 Weight Loss/Dietary Products
1.3.8 Ophthalmic Products
1.3.9 Sleeping Aids
1.3.10 Others
1.4 Global Over The Counter (OTC) Drugs Market by Application
1.4.1 Overview: Global Over The Counter (OTC) Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacy
1.4.5 Others
1.5 Global Over The Counter (OTC) Drugs Market Size & Forecast
1.6 Global Over The Counter (OTC) Drugs Market Size and Forecast by Region
1.6.1 Global Over The Counter (OTC) Drugs Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Over The Counter (OTC) Drugs Market Size by Region, (2019-2030)
1.6.3 North America Over The Counter (OTC) Drugs Market Size and Prospect (2019-2030)
1.6.4 Europe Over The Counter (OTC) Drugs Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Over The Counter (OTC) Drugs Market Size and Prospect (2019-2030)
1.6.6 South America Over The Counter (OTC) Drugs Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Over The Counter (OTC) Drugs Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Bayer AG
2.1.1 Bayer AG Details
2.1.2 Bayer AG Major Business
2.1.3 Bayer AG Over The Counter (OTC) Drugs Product and Solutions
2.1.4 Bayer AG Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bayer AG Recent Developments and Future Plans
2.2 Merck KGaA
2.2.1 Merck KGaA Details
2.2.2 Merck KGaA Major Business
2.2.3 Merck KGaA Over The Counter (OTC) Drugs Product and Solutions
2.2.4 Merck KGaA Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Merck KGaA Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Over The Counter (OTC) Drugs Product and Solutions
2.3.4 Novartis Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Over The Counter (OTC) Drugs Product and Solutions
2.4.4 Johnson & Johnson Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Over The Counter (OTC) Drugs Product and Solutions
2.5.4 GlaxoSmithKline Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 GlaxoSmithKline Recent Developments and Future Plans
2.6 Alkem Laboratories
2.6.1 Alkem Laboratories Details
2.6.2 Alkem Laboratories Major Business
2.6.3 Alkem Laboratories Over The Counter (OTC) Drugs Product and Solutions
2.6.4 Alkem Laboratories Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Alkem Laboratories Recent Developments and Future Plans
2.7 Teva Pharmaceutical Industries
2.7.1 Teva Pharmaceutical Industries Details
2.7.2 Teva Pharmaceutical Industries Major Business
2.7.3 Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Product and Solutions
2.7.4 Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Teva Pharmaceutical Industries Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Over The Counter (OTC) Drugs Product and Solutions
2.8.4 Pfizer Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Pfizer Recent Developments and Future Plans
2.9 Sun Pharma
2.9.1 Sun Pharma Details
2.9.2 Sun Pharma Major Business
2.9.3 Sun Pharma Over The Counter (OTC) Drugs Product and Solutions
2.9.4 Sun Pharma Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Sun Pharma Recent Developments and Future Plans
2.10 Allergan
2.10.1 Allergan Details
2.10.2 Allergan Major Business
2.10.3 Allergan Over The Counter (OTC) Drugs Product and Solutions
2.10.4 Allergan Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Allergan Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Over The Counter (OTC) Drugs Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Over The Counter (OTC) Drugs by Company Revenue
3.2.2 Top 3 Over The Counter (OTC) Drugs Players Market Share in 2023
3.2.3 Top 6 Over The Counter (OTC) Drugs Players Market Share in 2023
3.3 Over The Counter (OTC) Drugs Market: Overall Company Footprint Analysis
3.3.1 Over The Counter (OTC) Drugs Market: Region Footprint
3.3.2 Over The Counter (OTC) Drugs Market: Company Product Type Footprint
3.3.3 Over The Counter (OTC) Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Over The Counter (OTC) Drugs Consumption Value and Market Share by Type (2019-2024)
4.2 Global Over The Counter (OTC) Drugs Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Over The Counter (OTC) Drugs Consumption Value Market Share by Application (2019-2024)
5.2 Global Over The Counter (OTC) Drugs Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Over The Counter (OTC) Drugs Consumption Value by Type (2019-2030)
6.2 North America Over The Counter (OTC) Drugs Consumption Value by Application (2019-2030)
6.3 North America Over The Counter (OTC) Drugs Market Size by Country
6.3.1 North America Over The Counter (OTC) Drugs Consumption Value by Country (2019-2030)
6.3.2 United States Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
6.3.3 Canada Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
6.3.4 Mexico Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Over The Counter (OTC) Drugs Consumption Value by Type (2019-2030)
7.2 Europe Over The Counter (OTC) Drugs Consumption Value by Application (2019-2030)
7.3 Europe Over The Counter (OTC) Drugs Market Size by Country
7.3.1 Europe Over The Counter (OTC) Drugs Consumption Value by Country (2019-2030)
7.3.2 Germany Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
7.3.3 France Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
7.3.5 Russia Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
7.3.6 Italy Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Over The Counter (OTC) Drugs Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Over The Counter (OTC) Drugs Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region
8.3.1 Asia-Pacific Over The Counter (OTC) Drugs Consumption Value by Region (2019-2030)
8.3.2 China Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
8.3.3 Japan Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
8.3.4 South Korea Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
8.3.5 India Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
8.3.7 Australia Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Over The Counter (OTC) Drugs Consumption Value by Type (2019-2030)
9.2 South America Over The Counter (OTC) Drugs Consumption Value by Application (2019-2030)
9.3 South America Over The Counter (OTC) Drugs Market Size by Country
9.3.1 South America Over The Counter (OTC) Drugs Consumption Value by Country (2019-2030)
9.3.2 Brazil Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
9.3.3 Argentina Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Over The Counter (OTC) Drugs Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Over The Counter (OTC) Drugs Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country
10.3.1 Middle East & Africa Over The Counter (OTC) Drugs Consumption Value by Country (2019-2030)
10.3.2 Turkey Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
10.3.4 UAE Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Over The Counter (OTC) Drugs Market Drivers
11.2 Over The Counter (OTC) Drugs Market Restraints
11.3 Over The Counter (OTC) Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Over The Counter (OTC) Drugs Industry Chain
12.2 Over The Counter (OTC) Drugs Upstream Analysis
12.3 Over The Counter (OTC) Drugs Midstream Analysis
12.4 Over The Counter (OTC) Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Over The Counter (OTC) Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Over The Counter (OTC) Drugs by Type
1.3.1 Overview: Global Over The Counter (OTC) Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Over The Counter (OTC) Drugs Consumption Value Market Share by Type in 2023
1.3.3 Analgesics
1.3.4 Dermatology Products
1.3.5 Gastrointestinal Products
1.3.6 Vitamins, Mineral, and Supplements (VMS)
1.3.7 Weight Loss/Dietary Products
1.3.8 Ophthalmic Products
1.3.9 Sleeping Aids
1.3.10 Others
1.4 Global Over The Counter (OTC) Drugs Market by Application
1.4.1 Overview: Global Over The Counter (OTC) Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacy
1.4.5 Others
1.5 Global Over The Counter (OTC) Drugs Market Size & Forecast
1.6 Global Over The Counter (OTC) Drugs Market Size and Forecast by Region
1.6.1 Global Over The Counter (OTC) Drugs Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Over The Counter (OTC) Drugs Market Size by Region, (2019-2030)
1.6.3 North America Over The Counter (OTC) Drugs Market Size and Prospect (2019-2030)
1.6.4 Europe Over The Counter (OTC) Drugs Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Over The Counter (OTC) Drugs Market Size and Prospect (2019-2030)
1.6.6 South America Over The Counter (OTC) Drugs Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Over The Counter (OTC) Drugs Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Bayer AG
2.1.1 Bayer AG Details
2.1.2 Bayer AG Major Business
2.1.3 Bayer AG Over The Counter (OTC) Drugs Product and Solutions
2.1.4 Bayer AG Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bayer AG Recent Developments and Future Plans
2.2 Merck KGaA
2.2.1 Merck KGaA Details
2.2.2 Merck KGaA Major Business
2.2.3 Merck KGaA Over The Counter (OTC) Drugs Product and Solutions
2.2.4 Merck KGaA Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Merck KGaA Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Over The Counter (OTC) Drugs Product and Solutions
2.3.4 Novartis Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Over The Counter (OTC) Drugs Product and Solutions
2.4.4 Johnson & Johnson Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Over The Counter (OTC) Drugs Product and Solutions
2.5.4 GlaxoSmithKline Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 GlaxoSmithKline Recent Developments and Future Plans
2.6 Alkem Laboratories
2.6.1 Alkem Laboratories Details
2.6.2 Alkem Laboratories Major Business
2.6.3 Alkem Laboratories Over The Counter (OTC) Drugs Product and Solutions
2.6.4 Alkem Laboratories Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Alkem Laboratories Recent Developments and Future Plans
2.7 Teva Pharmaceutical Industries
2.7.1 Teva Pharmaceutical Industries Details
2.7.2 Teva Pharmaceutical Industries Major Business
2.7.3 Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Product and Solutions
2.7.4 Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Teva Pharmaceutical Industries Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Over The Counter (OTC) Drugs Product and Solutions
2.8.4 Pfizer Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Pfizer Recent Developments and Future Plans
2.9 Sun Pharma
2.9.1 Sun Pharma Details
2.9.2 Sun Pharma Major Business
2.9.3 Sun Pharma Over The Counter (OTC) Drugs Product and Solutions
2.9.4 Sun Pharma Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Sun Pharma Recent Developments and Future Plans
2.10 Allergan
2.10.1 Allergan Details
2.10.2 Allergan Major Business
2.10.3 Allergan Over The Counter (OTC) Drugs Product and Solutions
2.10.4 Allergan Over The Counter (OTC) Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Allergan Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Over The Counter (OTC) Drugs Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Over The Counter (OTC) Drugs by Company Revenue
3.2.2 Top 3 Over The Counter (OTC) Drugs Players Market Share in 2023
3.2.3 Top 6 Over The Counter (OTC) Drugs Players Market Share in 2023
3.3 Over The Counter (OTC) Drugs Market: Overall Company Footprint Analysis
3.3.1 Over The Counter (OTC) Drugs Market: Region Footprint
3.3.2 Over The Counter (OTC) Drugs Market: Company Product Type Footprint
3.3.3 Over The Counter (OTC) Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Over The Counter (OTC) Drugs Consumption Value and Market Share by Type (2019-2024)
4.2 Global Over The Counter (OTC) Drugs Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Over The Counter (OTC) Drugs Consumption Value Market Share by Application (2019-2024)
5.2 Global Over The Counter (OTC) Drugs Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Over The Counter (OTC) Drugs Consumption Value by Type (2019-2030)
6.2 North America Over The Counter (OTC) Drugs Consumption Value by Application (2019-2030)
6.3 North America Over The Counter (OTC) Drugs Market Size by Country
6.3.1 North America Over The Counter (OTC) Drugs Consumption Value by Country (2019-2030)
6.3.2 United States Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
6.3.3 Canada Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
6.3.4 Mexico Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Over The Counter (OTC) Drugs Consumption Value by Type (2019-2030)
7.2 Europe Over The Counter (OTC) Drugs Consumption Value by Application (2019-2030)
7.3 Europe Over The Counter (OTC) Drugs Market Size by Country
7.3.1 Europe Over The Counter (OTC) Drugs Consumption Value by Country (2019-2030)
7.3.2 Germany Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
7.3.3 France Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
7.3.5 Russia Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
7.3.6 Italy Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Over The Counter (OTC) Drugs Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Over The Counter (OTC) Drugs Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region
8.3.1 Asia-Pacific Over The Counter (OTC) Drugs Consumption Value by Region (2019-2030)
8.3.2 China Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
8.3.3 Japan Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
8.3.4 South Korea Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
8.3.5 India Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
8.3.7 Australia Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Over The Counter (OTC) Drugs Consumption Value by Type (2019-2030)
9.2 South America Over The Counter (OTC) Drugs Consumption Value by Application (2019-2030)
9.3 South America Over The Counter (OTC) Drugs Market Size by Country
9.3.1 South America Over The Counter (OTC) Drugs Consumption Value by Country (2019-2030)
9.3.2 Brazil Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
9.3.3 Argentina Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Over The Counter (OTC) Drugs Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Over The Counter (OTC) Drugs Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country
10.3.1 Middle East & Africa Over The Counter (OTC) Drugs Consumption Value by Country (2019-2030)
10.3.2 Turkey Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
10.3.4 UAE Over The Counter (OTC) Drugs Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Over The Counter (OTC) Drugs Market Drivers
11.2 Over The Counter (OTC) Drugs Market Restraints
11.3 Over The Counter (OTC) Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Over The Counter (OTC) Drugs Industry Chain
12.2 Over The Counter (OTC) Drugs Upstream Analysis
12.3 Over The Counter (OTC) Drugs Midstream Analysis
12.4 Over The Counter (OTC) Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Over The Counter (OTC) Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Over The Counter (OTC) Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Over The Counter (OTC) Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Over The Counter (OTC) Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Bayer AG Company Information, Head Office, and Major Competitors
Table 6. Bayer AG Major Business
Table 7. Bayer AG Over The Counter (OTC) Drugs Product and Solutions
Table 8. Bayer AG Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Bayer AG Recent Developments and Future Plans
Table 10. Merck KGaA Company Information, Head Office, and Major Competitors
Table 11. Merck KGaA Major Business
Table 12. Merck KGaA Over The Counter (OTC) Drugs Product and Solutions
Table 13. Merck KGaA Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Merck KGaA Recent Developments and Future Plans
Table 15. Novartis Company Information, Head Office, and Major Competitors
Table 16. Novartis Major Business
Table 17. Novartis Over The Counter (OTC) Drugs Product and Solutions
Table 18. Novartis Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Novartis Recent Developments and Future Plans
Table 20. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 21. Johnson & Johnson Major Business
Table 22. Johnson & Johnson Over The Counter (OTC) Drugs Product and Solutions
Table 23. Johnson & Johnson Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Johnson & Johnson Recent Developments and Future Plans
Table 25. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 26. GlaxoSmithKline Major Business
Table 27. GlaxoSmithKline Over The Counter (OTC) Drugs Product and Solutions
Table 28. GlaxoSmithKline Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. GlaxoSmithKline Recent Developments and Future Plans
Table 30. Alkem Laboratories Company Information, Head Office, and Major Competitors
Table 31. Alkem Laboratories Major Business
Table 32. Alkem Laboratories Over The Counter (OTC) Drugs Product and Solutions
Table 33. Alkem Laboratories Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Alkem Laboratories Recent Developments and Future Plans
Table 35. Teva Pharmaceutical Industries Company Information, Head Office, and Major Competitors
Table 36. Teva Pharmaceutical Industries Major Business
Table 37. Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Product and Solutions
Table 38. Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Teva Pharmaceutical Industries Recent Developments and Future Plans
Table 40. Pfizer Company Information, Head Office, and Major Competitors
Table 41. Pfizer Major Business
Table 42. Pfizer Over The Counter (OTC) Drugs Product and Solutions
Table 43. Pfizer Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Pfizer Recent Developments and Future Plans
Table 45. Sun Pharma Company Information, Head Office, and Major Competitors
Table 46. Sun Pharma Major Business
Table 47. Sun Pharma Over The Counter (OTC) Drugs Product and Solutions
Table 48. Sun Pharma Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Sun Pharma Recent Developments and Future Plans
Table 50. Allergan Company Information, Head Office, and Major Competitors
Table 51. Allergan Major Business
Table 52. Allergan Over The Counter (OTC) Drugs Product and Solutions
Table 53. Allergan Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Allergan Recent Developments and Future Plans
Table 55. Global Over The Counter (OTC) Drugs Revenue (USD Million) by Players (2019-2024)
Table 56. Global Over The Counter (OTC) Drugs Revenue Share by Players (2019-2024)
Table 57. Breakdown of Over The Counter (OTC) Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Over The Counter (OTC) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Over The Counter (OTC) Drugs Players
Table 60. Over The Counter (OTC) Drugs Market: Company Product Type Footprint
Table 61. Over The Counter (OTC) Drugs Market: Company Product Application Footprint
Table 62. Over The Counter (OTC) Drugs New Market Entrants and Barriers to Market Entry
Table 63. Over The Counter (OTC) Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Over The Counter (OTC) Drugs Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Over The Counter (OTC) Drugs Consumption Value Share by Type (2019-2024)
Table 66. Global Over The Counter (OTC) Drugs Consumption Value Forecast by Type (2025-2030)
Table 67. Global Over The Counter (OTC) Drugs Consumption Value by Application (2019-2024)
Table 68. Global Over The Counter (OTC) Drugs Consumption Value Forecast by Application (2025-2030)
Table 69. North America Over The Counter (OTC) Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Over The Counter (OTC) Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Over The Counter (OTC) Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Over The Counter (OTC) Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Over The Counter (OTC) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Over The Counter (OTC) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Over The Counter (OTC) Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Over The Counter (OTC) Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Over The Counter (OTC) Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Over The Counter (OTC) Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Over The Counter (OTC) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Over The Counter (OTC) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Over The Counter (OTC) Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Over The Counter (OTC) Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Over The Counter (OTC) Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Over The Counter (OTC) Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Over The Counter (OTC) Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Over The Counter (OTC) Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Over The Counter (OTC) Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Over The Counter (OTC) Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Over The Counter (OTC) Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Over The Counter (OTC) Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Over The Counter (OTC) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Over The Counter (OTC) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Over The Counter (OTC) Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Over The Counter (OTC) Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Over The Counter (OTC) Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Over The Counter (OTC) Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Over The Counter (OTC) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Over The Counter (OTC) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Over The Counter (OTC) Drugs Raw Material
Table 100. Key Suppliers of Over The Counter (OTC) Drugs Raw Materials
Table 1. Global Over The Counter (OTC) Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Over The Counter (OTC) Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Over The Counter (OTC) Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Over The Counter (OTC) Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Bayer AG Company Information, Head Office, and Major Competitors
Table 6. Bayer AG Major Business
Table 7. Bayer AG Over The Counter (OTC) Drugs Product and Solutions
Table 8. Bayer AG Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Bayer AG Recent Developments and Future Plans
Table 10. Merck KGaA Company Information, Head Office, and Major Competitors
Table 11. Merck KGaA Major Business
Table 12. Merck KGaA Over The Counter (OTC) Drugs Product and Solutions
Table 13. Merck KGaA Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Merck KGaA Recent Developments and Future Plans
Table 15. Novartis Company Information, Head Office, and Major Competitors
Table 16. Novartis Major Business
Table 17. Novartis Over The Counter (OTC) Drugs Product and Solutions
Table 18. Novartis Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Novartis Recent Developments and Future Plans
Table 20. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 21. Johnson & Johnson Major Business
Table 22. Johnson & Johnson Over The Counter (OTC) Drugs Product and Solutions
Table 23. Johnson & Johnson Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Johnson & Johnson Recent Developments and Future Plans
Table 25. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 26. GlaxoSmithKline Major Business
Table 27. GlaxoSmithKline Over The Counter (OTC) Drugs Product and Solutions
Table 28. GlaxoSmithKline Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. GlaxoSmithKline Recent Developments and Future Plans
Table 30. Alkem Laboratories Company Information, Head Office, and Major Competitors
Table 31. Alkem Laboratories Major Business
Table 32. Alkem Laboratories Over The Counter (OTC) Drugs Product and Solutions
Table 33. Alkem Laboratories Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Alkem Laboratories Recent Developments and Future Plans
Table 35. Teva Pharmaceutical Industries Company Information, Head Office, and Major Competitors
Table 36. Teva Pharmaceutical Industries Major Business
Table 37. Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Product and Solutions
Table 38. Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Teva Pharmaceutical Industries Recent Developments and Future Plans
Table 40. Pfizer Company Information, Head Office, and Major Competitors
Table 41. Pfizer Major Business
Table 42. Pfizer Over The Counter (OTC) Drugs Product and Solutions
Table 43. Pfizer Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Pfizer Recent Developments and Future Plans
Table 45. Sun Pharma Company Information, Head Office, and Major Competitors
Table 46. Sun Pharma Major Business
Table 47. Sun Pharma Over The Counter (OTC) Drugs Product and Solutions
Table 48. Sun Pharma Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Sun Pharma Recent Developments and Future Plans
Table 50. Allergan Company Information, Head Office, and Major Competitors
Table 51. Allergan Major Business
Table 52. Allergan Over The Counter (OTC) Drugs Product and Solutions
Table 53. Allergan Over The Counter (OTC) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Allergan Recent Developments and Future Plans
Table 55. Global Over The Counter (OTC) Drugs Revenue (USD Million) by Players (2019-2024)
Table 56. Global Over The Counter (OTC) Drugs Revenue Share by Players (2019-2024)
Table 57. Breakdown of Over The Counter (OTC) Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Over The Counter (OTC) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Over The Counter (OTC) Drugs Players
Table 60. Over The Counter (OTC) Drugs Market: Company Product Type Footprint
Table 61. Over The Counter (OTC) Drugs Market: Company Product Application Footprint
Table 62. Over The Counter (OTC) Drugs New Market Entrants and Barriers to Market Entry
Table 63. Over The Counter (OTC) Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Over The Counter (OTC) Drugs Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Over The Counter (OTC) Drugs Consumption Value Share by Type (2019-2024)
Table 66. Global Over The Counter (OTC) Drugs Consumption Value Forecast by Type (2025-2030)
Table 67. Global Over The Counter (OTC) Drugs Consumption Value by Application (2019-2024)
Table 68. Global Over The Counter (OTC) Drugs Consumption Value Forecast by Application (2025-2030)
Table 69. North America Over The Counter (OTC) Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Over The Counter (OTC) Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Over The Counter (OTC) Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Over The Counter (OTC) Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Over The Counter (OTC) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Over The Counter (OTC) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Over The Counter (OTC) Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Over The Counter (OTC) Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Over The Counter (OTC) Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Over The Counter (OTC) Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Over The Counter (OTC) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Over The Counter (OTC) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Over The Counter (OTC) Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Over The Counter (OTC) Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Over The Counter (OTC) Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Over The Counter (OTC) Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Over The Counter (OTC) Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Over The Counter (OTC) Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Over The Counter (OTC) Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Over The Counter (OTC) Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Over The Counter (OTC) Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Over The Counter (OTC) Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Over The Counter (OTC) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Over The Counter (OTC) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Over The Counter (OTC) Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Over The Counter (OTC) Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Over The Counter (OTC) Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Over The Counter (OTC) Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Over The Counter (OTC) Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Over The Counter (OTC) Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Over The Counter (OTC) Drugs Raw Material
Table 100. Key Suppliers of Over The Counter (OTC) Drugs Raw Materials
LIST OF FIGURES
Figure 1. Over The Counter (OTC) Drugs Picture
Figure 2. Global Over The Counter (OTC) Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Over The Counter (OTC) Drugs Consumption Value Market Share by Type in 2023
Figure 4. Analgesics
Figure 5. Dermatology Products
Figure 6. Gastrointestinal Products
Figure 7. Vitamins, Mineral, and Supplements (VMS)
Figure 8. Weight Loss/Dietary Products
Figure 9. Ophthalmic Products
Figure 10. Sleeping Aids
Figure 11. Others
Figure 12. Global Over The Counter (OTC) Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 13. Over The Counter (OTC) Drugs Consumption Value Market Share by Application in 2023
Figure 14. Hospital Pharmacies Picture
Figure 15. Retail Pharmacies Picture
Figure 16. Online Pharmacy Picture
Figure 17. Others Picture
Figure 18. Global Over The Counter (OTC) Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 19. Global Over The Counter (OTC) Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 20. Global Market Over The Counter (OTC) Drugs Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 21. Global Over The Counter (OTC) Drugs Consumption Value Market Share by Region (2019-2030)
Figure 22. Global Over The Counter (OTC) Drugs Consumption Value Market Share by Region in 2023
Figure 23. North America Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East and Africa Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Over The Counter (OTC) Drugs Revenue Share by Players in 2023
Figure 29. Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 30. Global Top 3 Players Over The Counter (OTC) Drugs Market Share in 2023
Figure 31. Global Top 6 Players Over The Counter (OTC) Drugs Market Share in 2023
Figure 32. Global Over The Counter (OTC) Drugs Consumption Value Share by Type (2019-2024)
Figure 33. Global Over The Counter (OTC) Drugs Market Share Forecast by Type (2025-2030)
Figure 34. Global Over The Counter (OTC) Drugs Consumption Value Share by Application (2019-2024)
Figure 35. Global Over The Counter (OTC) Drugs Market Share Forecast by Application (2025-2030)
Figure 36. North America Over The Counter (OTC) Drugs Consumption Value Market Share by Type (2019-2030)
Figure 37. North America Over The Counter (OTC) Drugs Consumption Value Market Share by Application (2019-2030)
Figure 38. North America Over The Counter (OTC) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 40. Canada Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 41. Mexico Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 42. Europe Over The Counter (OTC) Drugs Consumption Value Market Share by Type (2019-2030)
Figure 43. Europe Over The Counter (OTC) Drugs Consumption Value Market Share by Application (2019-2030)
Figure 44. Europe Over The Counter (OTC) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 46. France Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 47. United Kingdom Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 48. Russia Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 49. Italy Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Over The Counter (OTC) Drugs Consumption Value Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Over The Counter (OTC) Drugs Consumption Value Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Over The Counter (OTC) Drugs Consumption Value Market Share by Region (2019-2030)
Figure 53. China Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 54. Japan Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 55. South Korea Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 56. India Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 57. Southeast Asia Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 58. Australia Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 59. South America Over The Counter (OTC) Drugs Consumption Value Market Share by Type (2019-2030)
Figure 60. South America Over The Counter (OTC) Drugs Consumption Value Market Share by Application (2019-2030)
Figure 61. South America Over The Counter (OTC) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 63. Argentina Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 64. Middle East and Africa Over The Counter (OTC) Drugs Consumption Value Market Share by Type (2019-2030)
Figure 65. Middle East and Africa Over The Counter (OTC) Drugs Consumption Value Market Share by Application (2019-2030)
Figure 66. Middle East and Africa Over The Counter (OTC) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 67. Turkey Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 68. Saudi Arabia Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 69. UAE Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 70. Over The Counter (OTC) Drugs Market Drivers
Figure 71. Over The Counter (OTC) Drugs Market Restraints
Figure 72. Over The Counter (OTC) Drugs Market Trends
Figure 73. Porters Five Forces Analysis
Figure 74. Manufacturing Cost Structure Analysis of Over The Counter (OTC) Drugs in 2023
Figure 75. Manufacturing Process Analysis of Over The Counter (OTC) Drugs
Figure 76. Over The Counter (OTC) Drugs Industrial Chain
Figure 77. Methodology
Figure 78. Research Process and Data Source
Figure 1. Over The Counter (OTC) Drugs Picture
Figure 2. Global Over The Counter (OTC) Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Over The Counter (OTC) Drugs Consumption Value Market Share by Type in 2023
Figure 4. Analgesics
Figure 5. Dermatology Products
Figure 6. Gastrointestinal Products
Figure 7. Vitamins, Mineral, and Supplements (VMS)
Figure 8. Weight Loss/Dietary Products
Figure 9. Ophthalmic Products
Figure 10. Sleeping Aids
Figure 11. Others
Figure 12. Global Over The Counter (OTC) Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 13. Over The Counter (OTC) Drugs Consumption Value Market Share by Application in 2023
Figure 14. Hospital Pharmacies Picture
Figure 15. Retail Pharmacies Picture
Figure 16. Online Pharmacy Picture
Figure 17. Others Picture
Figure 18. Global Over The Counter (OTC) Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 19. Global Over The Counter (OTC) Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 20. Global Market Over The Counter (OTC) Drugs Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 21. Global Over The Counter (OTC) Drugs Consumption Value Market Share by Region (2019-2030)
Figure 22. Global Over The Counter (OTC) Drugs Consumption Value Market Share by Region in 2023
Figure 23. North America Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East and Africa Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Over The Counter (OTC) Drugs Revenue Share by Players in 2023
Figure 29. Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 30. Global Top 3 Players Over The Counter (OTC) Drugs Market Share in 2023
Figure 31. Global Top 6 Players Over The Counter (OTC) Drugs Market Share in 2023
Figure 32. Global Over The Counter (OTC) Drugs Consumption Value Share by Type (2019-2024)
Figure 33. Global Over The Counter (OTC) Drugs Market Share Forecast by Type (2025-2030)
Figure 34. Global Over The Counter (OTC) Drugs Consumption Value Share by Application (2019-2024)
Figure 35. Global Over The Counter (OTC) Drugs Market Share Forecast by Application (2025-2030)
Figure 36. North America Over The Counter (OTC) Drugs Consumption Value Market Share by Type (2019-2030)
Figure 37. North America Over The Counter (OTC) Drugs Consumption Value Market Share by Application (2019-2030)
Figure 38. North America Over The Counter (OTC) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 40. Canada Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 41. Mexico Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 42. Europe Over The Counter (OTC) Drugs Consumption Value Market Share by Type (2019-2030)
Figure 43. Europe Over The Counter (OTC) Drugs Consumption Value Market Share by Application (2019-2030)
Figure 44. Europe Over The Counter (OTC) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 46. France Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 47. United Kingdom Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 48. Russia Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 49. Italy Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Over The Counter (OTC) Drugs Consumption Value Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Over The Counter (OTC) Drugs Consumption Value Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Over The Counter (OTC) Drugs Consumption Value Market Share by Region (2019-2030)
Figure 53. China Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 54. Japan Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 55. South Korea Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 56. India Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 57. Southeast Asia Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 58. Australia Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 59. South America Over The Counter (OTC) Drugs Consumption Value Market Share by Type (2019-2030)
Figure 60. South America Over The Counter (OTC) Drugs Consumption Value Market Share by Application (2019-2030)
Figure 61. South America Over The Counter (OTC) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 63. Argentina Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 64. Middle East and Africa Over The Counter (OTC) Drugs Consumption Value Market Share by Type (2019-2030)
Figure 65. Middle East and Africa Over The Counter (OTC) Drugs Consumption Value Market Share by Application (2019-2030)
Figure 66. Middle East and Africa Over The Counter (OTC) Drugs Consumption Value Market Share by Country (2019-2030)
Figure 67. Turkey Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 68. Saudi Arabia Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 69. UAE Over The Counter (OTC) Drugs Consumption Value (2019-2030) & (USD Million)
Figure 70. Over The Counter (OTC) Drugs Market Drivers
Figure 71. Over The Counter (OTC) Drugs Market Restraints
Figure 72. Over The Counter (OTC) Drugs Market Trends
Figure 73. Porters Five Forces Analysis
Figure 74. Manufacturing Cost Structure Analysis of Over The Counter (OTC) Drugs in 2023
Figure 75. Manufacturing Process Analysis of Over The Counter (OTC) Drugs
Figure 76. Over The Counter (OTC) Drugs Industrial Chain
Figure 77. Methodology
Figure 78. Research Process and Data Source
